HARP - Harpoon Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - HARP (1708493)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
26 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2020-02-18
HARPSacks NatalieChief Medical OfficerS - Sale+OE$15.00-1,52145,754-3%-$22,815
D
2020-02-03
HARPSacks NatalieChief Medical OfficerS - Sale+OE$13.90-5,82645,754-11%-$81,006
2020-01-21
HARPErbez GeorgiaCFOP - Purchase$14.09+6,70053,992+14%+$94,418
D
2020-01-16
HARPSacks NatalieChief Medical OfficerS - Sale+OE$14.94-1,52145,754-3%-$22,725
D
2020-01-02
HARPWesche HolgerChief Scientific OfficerS - Sale+OE$14.40-10,00052,669-16%-$143,987
D
2020-01-02
HARPSacks NatalieChief Medical OfficerS - Sale+OE$14.18-5,82645,754-11%-$82,600
2019-12-27
HARPBaeuerle PatrickDirS - Sale$15.98-87,379262,136-25%-$1,396,281
D
2019-12-16
HARPSacks NatalieChief Medical OfficerS - Sale+OE$17.02-1,52145,754-3%-$25,888
M
2019-12-13
HARPChin MarkDir, 10%S - Sale$17.01-36,5582,572,359-1%-$621,990
M
2019-12-13
HARPArix Bioscience Plc10%S - Sale$17.01-36,5582,572,359-1%-$621,990
M
2019-12-06
HARPChin MarkDir, 10%S - Sale$17.75-283,2022,608,917-10%-$5,025,686
M
2019-12-06
HARPArix Bioscience Plc10%S - Sale$17.75-283,2022,608,917-10%-$5,025,686
D
2019-12-02
HARPSacks NatalieChief Medical OfficerS - Sale+OE$17.98-5,82645,754-11%-$104,751
D
2019-11-18
HARPSacks NatalieChief Medical OfficerS - Sale+OE$13.37-18,25245,754-29%-$243,964
D
2019-11-01
HARPSacks NatalieChief Medical OfficerS - Sale+OE$13.17-5,82645,754-11%-$76,702
DM
2019-10-14
HARPSacks NatalieChief Medical OfficerS - Sale+OE$13.24-24,15045,754-35%-$319,762
2019-05-14
HARPMcMahon Gerald PhdPres, CEOP - Purchase$10.16+1,0003,000+50%+$10,157
2019-05-08
HARPMcMahon Gerald PhdPres, CEOP - Purchase$10.56+1,0002,000+100%+$10,559
2019-05-03
HARPMcMahon Gerald PhdPres, CEOP - Purchase$10.53+1,0001,000New+$10,530
D
2019-02-12
HARPArix Bioscience Plc10%P - Purchase$14.00+428,5712,892,119+17%+$5,999,994
D
2019-02-12
HARPUbs Oncology Impact Fund L.P.10%P - Purchase$14.00+250,0003,898,422+7%+$3,500,000
D
2019-02-12
HARPUbs Oncology Impact Fund L.P.10%S - Sale+OE$14.00-4473,898,4220%-$6,258
D
2019-02-12
HARPNew Leaf Ventures Iii, L.P.10%P - Purchase$14.00+428,571678,566+171%+$5,999,994
D
2019-02-12
HARPMpm Bioventures 2014, L.P.10%P - Purchase$14.00+250,0004,524,425+6%+$3,500,000
D
2019-02-12
HARPMpm Bioventures 2014, L.P.10%S - Sale+OE$14.00-1,5244,524,4250%-$21,336
D
2019-02-12
HARPHunt RonaldDir, 10%P - Purchase$14.00+428,571678,566+171%+$5,999,994
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top